Synovus和Stifel公司增加了GMED的股权,收入猛增63.1%,而GEHC公司也超过了收入估算。 Synovus and Stifel increased stakes in GMED, which saw a 63.1% revenue jump, while GEHC also beat earnings estimates.

Synovus金融公司在第三季度Globus Medical(GMED)的股份增加了9.8%,而Stifel金融公司也增加了其股份。 Synovus Financial Corp increased its stake in Globus Medical (GMED) by 9.8% in the third quarter, while Stifel Financial Corp also boosted its holdings. GMED报告收入增长63.1%,EPS为0.83美元,殴打估计数。 GMED reported a 63.1% revenue increase and an EPS of $0.83, beating estimates. 分析师有一个“机动购买”共识,平均目标价为92.18美元。 Analysts have a "Moderate Buy" consensus, with a $92.18 average target price. 同时,机构投资者调整了自己在GE Ge HealthCare Technologies(GEHC)中的位置,对分析师的评级和价格目标各有不同。 Meanwhile, institutional investors adjusted their positions in GE HealthCare Technologies (GEHC), with varied analyst ratings and price targets. GEHC的Q3收入比值估算,该公司宣布季度红利为0.035美元。 GEHC's Q3 earnings beat estimates, and the company declared a quarterly dividend of $0.035.